Journal
TRENDS IN ENDOCRINOLOGY AND METABOLISM
Volume 17, Issue 3, Pages 117-121Publisher
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tem.2006.02.006
Keywords
-
Categories
Ask authors/readers for more resources
Mifepristone is a potent glucocorticoid and progesterone receptor antagonist. The pathophysiology of a number of neuropsychiatric disorders implicates abnormalities in glucocorticoid function. These include mood disorders such as psychotic major depression and bipolar depression. In addition, cognitive disorders such as Alzheimer's disease might also be partially mediated by abnormalities in the hypothalamic-pituitary-adrenal axis. Preliminary studies suggest that mifepristone might have a role in the treatment of a number of neuropsychiatric disorders.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available